Biogaia AB - ESG Rating & Company Profile powered by AI
Full ESG analysis of Biogaia AB are accessed by signing up for free. If you work at Biogaia AB and you wish to licence your Sustainability rating, please contact us. This dashboard includes a questions and answers section for Biogaia AB.
Biogaia AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Biogaia AB | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Biogaia AB have an accelerator or VC vehicle to help deliver innovation?
Does Biogaia AB disclose current and historical energy intensity?
Does Biogaia AB report the average age of the workforce?
Does Biogaia AB reference operational or capital allocation in relation to climate change?
Does Biogaia AB disclose its ethnicity pay gap?
Does Biogaia AB disclose cybersecurity risks?
Does Biogaia AB offer flexible work?
Does Biogaia AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Biogaia AB disclose the number of employees in R&D functions?
Does Biogaia AB conduct supply chain audits?
Does Biogaia AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Biogaia AB conduct 360 degree staff reviews?
Does Biogaia AB disclose the individual responsible for D&I?
Does Biogaia AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Biogaia AB disclose current and / or historical scope 2 emissions?
Does Biogaia AB disclose water use targets?
Does Biogaia AB have careers partnerships with academic institutions?
Did Biogaia AB have a product recall in the last two years?
Does Biogaia AB disclose incidents of discrimination?
Does Biogaia AB allow for Work Councils/Collective Agreements to be formed?
Has Biogaia AB issued a profit warning in the past 24 months?
Does Biogaia AB disclose parental leave metrics?
Does Biogaia AB disclose climate scenario or pathway analysis?
Does Biogaia AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Biogaia AB disclose the pay ratio of women to men?
Does Biogaia AB support suppliers with sustainability related research and development?
Does Biogaia AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Biogaia AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Biogaia AB involved in embryonic stem cell research?
Does Biogaia AB disclose GHG and Air Emissions intensity?
Does Biogaia AB disclose its waste policy?
Does Biogaia AB report according to TCFD requirements?
Does Biogaia AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Biogaia AB disclose energy use targets?
Does Biogaia AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Biogaia AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Biogaia AB
These potential risks are based on the size, segment and geographies of the company.
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori"the gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.